<DOC>
	<DOC>NCT01469377</DOC>
	<brief_summary>An outpatient study to evaluate the safety and efficacy of cariprazine as adjunct to Antidepressant Therapy (ADT) in patients with Major Depressive Disorder (MDD) who have an inadequate response to antidepressant alone. This clinical study will be comparing cariprazine + ADT with placebo + ADT in outpatients with a diagnosis of MDD and an inadequate response to ADT in the current episode. The study will consist of approximately 2 weeks of screening and washout followed by 8 weeks of double-blind treatment followed by a 1 week safety follow-up.</brief_summary>
	<brief_title>Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<criteria>Male or female outpatients 18 to 65 years of age, inclusive Currently meet the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSMIVTR) criteria for moderate to severe MDD Current major depressive episode of at least 8 weeks and not exceeding 24 months in duration Ongoing inadequate response to protocol allowed ADT Principal DSMIVTRbased diagnosis of an axis I disorder, other than MDD, Women who are pregnant, or planning to become pregnant or breastfeed during the study or not practicing reliable contraception that will continue through out the study History of meeting DSMIVTR criteria for: 1. Depressive episode with psychotic or catatonic features 2. Manic, hypomanic or mixed episode, including bipolar disorder and substance induced manic, hypomanic or mixed episode 3. Schizophrenia, schizoaffective, or other psychotic disorder 4. Obsessivecompulsive disorder 5. Bulimia or anorexia nervosa 6. Dementia, amnesic, or other cognitive disorder 7. Mental retardation Patients considered a suicide risk</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
</DOC>